Cepheid to sponsor BASHH 2013 Spring Meeting
Leading molecular diagnostics company Cepheid is helping to bring together prominent scientists and clinicians from across the UK at the British Association for Sexual Health and HIV (BASHH) 2013 Spring Meeting, where the latest healthcare trends and scientific breakthroughs in this important field will be discussed.
- (1888PressRelease) May 09, 2013 - A platinum sponsor of the event - held from the 15th to the 17th of May in Bristol - Cepheid will be showcasing the latest addition to the GeneXpert® test menu, Xpert® CT/NG, on booth 19 at the accompanying exhibition.
The meeting's diverse programme includes a Cepheid-sponsored lecture on Assessing the costs and benefits of point of care tests for STIs from invited speaker Dr Elisabeth Adams, Director and Founder of Aquarius Population Health and an Honorary Researcher at the University of Bristol.
Visitors to the Cepheid exhibition stand will discover the advantages of the Xpert CT/NG qualitative in vitro molecular diagnostic test for the rapid detection and differentiation of Chlamydia trachomatis (CT) and Neisseria gonorrhoeae (NG).
This easy-to-use, FDA-approved and CE-marked on-demand molecular test uses two independent NG DNA targets for high specificity and a CT target exclusively selected for superior inclusivity. A Sample Adequacy Control (SAC) is also included, to prevent false negative results where no human cells are present. Accurate results are delivered in just 90 minutes, contributing to effective patient and disease management by giving clinicians the opportunity to provide same-day consultation and treatment.
For more information, visit Cepheid at booth 19 or go to www.cepheidinternational.com
###
space
space
Satisfied Users & 
Approved Press Releases
Print
Email
Report Spam